APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-protein Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bio-protein Drug Industry Growth and Trends Forecast to 2032

26 December 2025114 pages

Choose your research edition.

Industry ResearchBio-protein Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-protein Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Bio-protein Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-protein Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-protein Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Bio-protein Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bio-protein Drug include Abbott Laboratories, Sanofi, Johnson & Johnson, Novartis AG, Merck, Roche, GlaxoSmithKline, Bayer AG and Amgen Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bio-protein Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bio-protein Drug market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bio-protein Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bio-protein Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bio-protein Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bio-protein Drug Market by Company

Abbott Laboratories

Sanofi

Johnson & Johnson

Novartis AG

Merck

Roche

GlaxoSmithKline

Bayer AG

Amgen Inc.

Reliance Life Science Pvt. Ltd.

ProBioGen AG

Panacea Biotec

Fresenius kabi

Eli Lilly and Company

Dr. Reddy’s Laboratories

Biocon Ltd.

Bio-protein Drug Segment by Type

Therapeutic Proteins

Vaccines

Monoclonal Antibodies

Bio-protein Drug Segment by Application

CROs

Academics

Pharma and Biotech Companies

Bio-protein Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-protein Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-protein Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-protein Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bio-protein Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bio-protein Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Therapeutic Proteins Table 2. Major Company of Vaccines Table 3. Major Company of Monoclonal Antibodies Table 4. Global Bio-protein Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 6. Global Bio-protein Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Bio-protein Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Bio-protein Drug Price by Type (2021-2026) & (US$/Ton) Table 10. Global Bio-protein Drug Sales by Type (2027-2032) & (W Tons) Table 11. Global Bio-protein Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Bio-protein Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Bio-protein Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Bio-protein Drug Price by Type (2027-2032) & (US$/Ton) Table 15. North America Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 16. North America Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 18. Europe Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 20. Asia-Pacific Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 22. Latin America Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 24. Middle East and Africa Bio-protein Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Bio-protein Drug Industry Trends Table 26. Bio-protein Drug Industry Drivers Table 27. Bio-protein Drug Industry Opportunities and Challenges Table 28. Bio-protein Drug Industry Restraints Table 29. Global Bio-protein Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Bio-protein Drug Revenue Market Share by Company (2021-2026) Table 31. Global Bio-protein Drug Sales by Company (2021-2026) & (W Tons) Table 32. Global Bio-protein Drug Sales Share by Company (2021-2026) Table 33. Global Bio-protein Drug Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Bio-protein Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bio-protein Drug Major Company Production Sites and Headquarters Table 36. Global Bio-protein Drug Company, Product Type & Application Table 37. Global Bio-protein Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Bio-protein Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Bio-protein Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Bio-protein Drug Sales by Region (2021-2026) & (W Tons) Table 42. Global Bio-protein Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Bio-protein Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Bio-protein Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Bio-protein Drug Sales by Region (2027-2032) & (W Tons) Table 47. Global Bio-protein Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Bio-protein Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Bio-protein Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Bio-protein Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 53. Global Bio-protein Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Bio-protein Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Bio-protein Drug Price by Application (2021-2026) & (US$/Ton) Table 57. Global Bio-protein Drug Sales by Application (2027-2032) & (W Tons) Table 58. Global Bio-protein Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Bio-protein Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Bio-protein Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Bio-protein Drug Price by Application (2027-2032) & (US$/Ton) Table 62. North America Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 63. North America Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 65. Europe Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 67. Asia-Pacific Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 69. Latin America Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 71. Middle East and Africa Bio-protein Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Laboratories Company Information Table 73. Abbott Laboratories Business Overview Table 74. Abbott Laboratories Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Abbott Laboratories Bio-protein Drug Product Portfolio Table 76. Abbott Laboratories Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Sanofi Bio-protein Drug Product Portfolio Table 81. Sanofi Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Bio-protein Drug Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. Novartis AG Company Information Table 88. Novartis AG Business Overview Table 89. Novartis AG Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Novartis AG Bio-protein Drug Product Portfolio Table 91. Novartis AG Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Merck Bio-protein Drug Product Portfolio Table 96. Merck Recent Development Table 97. Roche Company Information Table 98. Roche Business Overview Table 99. Roche Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Roche Bio-protein Drug Product Portfolio Table 101. Roche Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Bio-protein Drug Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Bayer AG Company Information Table 108. Bayer AG Business Overview Table 109. Bayer AG Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Bayer AG Bio-protein Drug Product Portfolio Table 111. Bayer AG Recent Development Table 112. Amgen Inc. Company Information Table 113. Amgen Inc. Business Overview Table 114. Amgen Inc. Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Amgen Inc. Bio-protein Drug Product Portfolio Table 116. Amgen Inc. Recent Development Table 117. Reliance Life Science Pvt. Ltd. Company Information Table 118. Reliance Life Science Pvt. Ltd. Business Overview Table 119. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio Table 121. Reliance Life Science Pvt. Ltd. Recent Development Table 122. ProBioGen AG Company Information Table 123. ProBioGen AG Business Overview Table 124. ProBioGen AG Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. ProBioGen AG Bio-protein Drug Product Portfolio Table 126. ProBioGen AG Recent Development Table 127. Panacea Biotec Company Information Table 128. Panacea Biotec Business Overview Table 129. Panacea Biotec Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Panacea Biotec Bio-protein Drug Product Portfolio Table 131. Panacea Biotec Recent Development Table 132. Fresenius kabi Company Information Table 133. Fresenius kabi Business Overview Table 134. Fresenius kabi Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. Fresenius kabi Bio-protein Drug Product Portfolio Table 136. Fresenius kabi Recent Development Table 137. Eli Lilly and Company Company Information Table 138. Eli Lilly and Company Business Overview Table 139. Eli Lilly and Company Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. Eli Lilly and Company Bio-protein Drug Product Portfolio Table 141. Eli Lilly and Company Recent Development Table 142. Dr. Reddy’s Laboratories Company Information Table 143. Dr. Reddy’s Laboratories Business Overview Table 144. Dr. Reddy’s Laboratories Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio Table 146. Dr. Reddy’s Laboratories Recent Development Table 147. Biocon Ltd. Company Information Table 148. Biocon Ltd. Business Overview Table 149. Biocon Ltd. Bio-protein Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 150. Biocon Ltd. Bio-protein Drug Product Portfolio Table 151. Biocon Ltd. Recent Development Table 152. North America Bio-protein Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 153. North America Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 154. North America Bio-protein Drug Sales Market Share by Country (2021-2026) Table 155. North America Bio-protein Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 156. North America Bio-protein Drug Sales Market Share Forecast by Country (2027-2032) Table 157. North America Bio-protein Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Bio-protein Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Bio-protein Drug Market Share by Country (2021-2026) Table 160. North America Bio-protein Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Bio-protein Drug Market Share Forecast by Country (2027-2032) Table 162. Europe Bio-protein Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 163. Europe Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 164. Europe Bio-protein Drug Sales Market Share by Country (2021-2026) Table 165. Europe Bio-protein Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 166. Europe Bio-protein Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Bio-protein Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Bio-protein Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Bio-protein Drug Market Share by Country (2021-2026) Table 170. Europe Bio-protein Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Bio-protein Drug Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Bio-protein Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 174. Asia-Pacific Bio-protein Drug Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Bio-protein Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 176. Asia-Pacific Bio-protein Drug Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Bio-protein Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Bio-protein Drug Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Bio-protein Drug Market Share by Country (2021-2026) Table 180. Asia-Pacific Bio-protein Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Bio-protein Drug Market Share Forecast by Country (2027-2032) Table 182. Latin America Bio-protein Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 183. Latin America Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 184. Latin America Bio-protein Drug Sales Market Share by Country (2021-2026) Table 185. Latin America Bio-protein Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 186. Latin America Bio-protein Drug Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Bio-protein Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Bio-protein Drug Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Bio-protein Drug Market Share by Country (2021-2026) Table 190. Latin America Bio-protein Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Bio-protein Drug Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Bio-protein Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 194. Middle East and Africa Bio-protein Drug Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Bio-protein Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 196. Middle East and Africa Bio-protein Drug Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Bio-protein Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Bio-protein Drug Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Bio-protein Drug Market Share by Country (2021-2026) Table 200. Middle East and Africa Bio-protein Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Bio-protein Drug Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Bio-protein Drug Distributors List Table 205. Bio-protein Drug Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Bio-protein Drug Image Figure 2. Global Bio-protein Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-protein Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio-protein Drug Sales (2021-2032) & (W Tons) Figure 5. Therapeutic Proteins Image Figure 6. Global Therapeutic Proteins Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Vaccines Image Figure 8. Global Vaccines Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Monoclonal Antibodies Image Figure 10. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Global Bio-protein Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Bio-protein Drug Market Share by Type 2025 VS 2032 Figure 13. North America Bio-protein Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Bio-protein Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Bio-protein Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Bio-protein Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Bio-protein Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Bio-protein Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Bio-protein Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Bio-protein Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. CROs Image Figure 26. Global CROs Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Academics Image Figure 28. Global Academics Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Pharma and Biotech Companies Image Figure 30. Global Pharma and Biotech Companies Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Global Bio-protein Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Bio-protein Drug Market Share by Application 2025 VS 2032 Figure 33. North America Bio-protein Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Bio-protein Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Bio-protein Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Bio-protein Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Bio-protein Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Bio-protein Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Bio-protein Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Bio-protein Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Bio-protein Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Bio-protein Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 44. North America Bio-protein Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Bio-protein Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Bio-protein Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. Europe Bio-protein Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bio-protein Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Bio-protein Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Asia-Pacific Bio-protein Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bio-protein Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Bio-protein Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Latin America Bio-protein Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bio-protein Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Bio-protein Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Middle East and Africa Bio-protein Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bio-protein Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Bio-protein Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Bio-protein Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Bio-protein Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Proteins
  • Vaccines
  • Monoclonal Antibodies
Applications
  • CROs
  • Academics
  • Pharma and Biotech Companies
Companies covered
  • Abbott Laboratories
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Merck
  • Roche
  • GlaxoSmithKline
  • Bayer AG
  • Amgen Inc.
  • Reliance Life Science Pvt. Ltd.
  • ProBioGen AG
  • Panacea Biotec
  • Fresenius kabi
  • Eli Lilly and Company
  • Dr. Reddy’s Laboratories
  • Biocon Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio-protein Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bio-protein Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bio-protein Drug Market by Type
  6. 1.3.1 Therapeutic Proteins
  7. 1.3.2 Vaccines
  8. 1.3.3 Monoclonal Antibodies
  9. 1.4 Global Bio-protein Drug Market Size by Type
  10. 1.4.1 Global Bio-protein Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Bio-protein Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Bio-protein Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Bio-protein Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Bio-protein Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Bio-protein Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Bio-protein Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Bio-protein Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bio-protein Drug Industry Trends
  2. 2.2 Bio-protein Drug Industry Drivers
  3. 2.3 Bio-protein Drug Industry Opportunities and Challenges
  4. 2.4 Bio-protein Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bio-protein Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Bio-protein Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Bio-protein Drug Price (2021-2026)
  4. 3.4 Global Bio-protein Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bio-protein Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Bio-protein Drug Company, Product Type & Application
  7. 3.7 Global Bio-protein Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bio-protein Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bio-protein Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bio-protein Drug Tier 1, Tier 2, and Tier 3
4 Bio-protein Drug Regional Status and Outlook
  1. 4.1 Global Bio-protein Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bio-protein Drug Historic Market Size by Region
  3. 4.2.1 Global Bio-protein Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bio-protein Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bio-protein Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bio-protein Drug Forecasted Market Size by Region
  7. 4.3.1 Global Bio-protein Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bio-protein Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bio-protein Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bio-protein Drug by Application
  1. 5.1 Bio-protein Drug Market by Application
  2. 5.1.1 CROs
  3. 5.1.2 Academics
  4. 5.1.3 Pharma and Biotech Companies
  5. 5.2 Global Bio-protein Drug Market Size by Application
  6. 5.2.1 Global Bio-protein Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bio-protein Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bio-protein Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bio-protein Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bio-protein Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bio-protein Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bio-protein Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bio-protein Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Bio-protein Drug Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Bio-protein Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Bio-protein Drug Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG Bio-protein Drug Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Bio-protein Drug Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Bio-protein Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Bio-protein Drug Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer AG
  44. 6.8.1 Bayer AG Company Information
  45. 6.8.2 Bayer AG Business Overview
  46. 6.8.3 Bayer AG Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer AG Bio-protein Drug Product Portfolio
  48. 6.8.5 Bayer AG Recent Developments
  49. 6.9 Amgen Inc.
  50. 6.9.1 Amgen Inc. Company Information
  51. 6.9.2 Amgen Inc. Business Overview
  52. 6.9.3 Amgen Inc. Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Amgen Inc. Bio-protein Drug Product Portfolio
  54. 6.9.5 Amgen Inc. Recent Developments
  55. 6.10 Reliance Life Science Pvt. Ltd.
  56. 6.10.1 Reliance Life Science Pvt. Ltd. Company Information
  57. 6.10.2 Reliance Life Science Pvt. Ltd. Business Overview
  58. 6.10.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio
  60. 6.10.5 Reliance Life Science Pvt. Ltd. Recent Developments
  61. 6.11 ProBioGen AG
  62. 6.11.1 ProBioGen AG Company Information
  63. 6.11.2 ProBioGen AG Business Overview
  64. 6.11.3 ProBioGen AG Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ProBioGen AG Bio-protein Drug Product Portfolio
  66. 6.11.5 ProBioGen AG Recent Developments
  67. 6.12 Panacea Biotec
  68. 6.12.1 Panacea Biotec Company Information
  69. 6.12.2 Panacea Biotec Business Overview
  70. 6.12.3 Panacea Biotec Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Panacea Biotec Bio-protein Drug Product Portfolio
  72. 6.12.5 Panacea Biotec Recent Developments
  73. 6.13 Fresenius kabi
  74. 6.13.1 Fresenius kabi Company Information
  75. 6.13.2 Fresenius kabi Business Overview
  76. 6.13.3 Fresenius kabi Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Fresenius kabi Bio-protein Drug Product Portfolio
  78. 6.13.5 Fresenius kabi Recent Developments
  79. 6.14 Eli Lilly and Company
  80. 6.14.1 Eli Lilly and Company Company Information
  81. 6.14.2 Eli Lilly and Company Business Overview
  82. 6.14.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eli Lilly and Company Bio-protein Drug Product Portfolio
  84. 6.14.5 Eli Lilly and Company Recent Developments
  85. 6.15 Dr. Reddy’s Laboratories
  86. 6.15.1 Dr. Reddy’s Laboratories Company Information
  87. 6.15.2 Dr. Reddy’s Laboratories Business Overview
  88. 6.15.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio
  90. 6.15.5 Dr. Reddy’s Laboratories Recent Developments
  91. 6.16 Biocon Ltd.
  92. 6.16.1 Biocon Ltd. Company Information
  93. 6.16.2 Biocon Ltd. Business Overview
  94. 6.16.3 Biocon Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Biocon Ltd. Bio-protein Drug Product Portfolio
  96. 6.16.5 Biocon Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Bio-protein Drug Sales by Country
  2. 7.1.1 North America Bio-protein Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bio-protein Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Bio-protein Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bio-protein Drug Market Size by Country
  6. 7.2.1 North America Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bio-protein Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Bio-protein Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bio-protein Drug Sales by Country
  2. 8.1.1 Europe Bio-protein Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bio-protein Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Bio-protein Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bio-protein Drug Market Size by Country
  6. 8.2.1 Europe Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bio-protein Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bio-protein Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bio-protein Drug Sales by Country
  2. 9.1.1 Asia-Pacific Bio-protein Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bio-protein Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bio-protein Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bio-protein Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bio-protein Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bio-protein Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bio-protein Drug Sales by Country
  2. 10.1.1 South America Bio-protein Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bio-protein Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Bio-protein Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bio-protein Drug Market Size by Country
  6. 10.2.1 South America Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bio-protein Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Bio-protein Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bio-protein Drug Sales by Country
  2. 11.1.1 Middle East and Africa Bio-protein Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bio-protein Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bio-protein Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bio-protein Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Bio-protein Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bio-protein Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bio-protein Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bio-protein Drug Value Chain Analysis
  2. 12.1.1 Bio-protein Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bio-protein Drug Production Mode & Process
  7. 12.2 Bio-protein Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bio-protein Drug Distributors
  10. 12.2.3 Bio-protein Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst